Message Font: Serif | Sans-Serif
No. of Recommendations: 0

Abraxis Advances
By Brian Lawler
November 7, 2006

Nothing gets pharmaceutical investors more lathered-up than a drug developer with a so-called platform technology -- one that can be used to make existing drugs more potent, longer lasting, or safer, for example. Platform technologies are so exciting because they can potentially be applied across many already approved drugs, capturing a good chunk of an existing drug's market share. This is why investors have been so excited about Abraxis BioScience (Nasdaq: ABBI) since the approval of its cancer-treating compound, Abraxane, back in early 2005......
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.